NASDAQ:GTBP
GT Biopharma, Inc.
- Stock
Last Close
2.72
26/07 20:00
Market Cap
6.06M
Beta: 0.86
Volume Today
2.40K
Avg: 131.26K
PE Ratio
−15.25
PFCF: −19.13
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -501K - | -23.49M 4,588.42% | -32.73M 39.32% | 21.03M 164.27% | -143.25M 781.06% | -259.19M 80.94% | -38.65M 85.09% | -28.30M 26.78% | -58.01M 105.02% | -20.88M 64.00% | -7.60M 63.62% | |
depreciation and amortization | 2K - | 22K 1,000% | 2K 90.91% | 1K 50% | 2K 100% | 7K 250% | 4K 42.86% | 317K 7,825% | ||||
deferred income tax | -736K - | 16.72M 2,371.88% | 9.89M 40.83% | -34.06M 444.30% | 4.91M 114.43% | 228.51M 4,550.28% | 25.09M 89.02% | -317K 101.26% | ||||
stock based compensation | 176K - | 2.63M 1,394.32% | 3.76M 43.00% | 6.59M 75.25% | 130.12M 1,874.27% | 9.70M 92.55% | 5.31M 45.26% | 269K 94.93% | 33.93M 12,513.01% | 7.65M 77.46% | 163K 97.87% | |
change in working capital | 477K - | -221K 146.33% | 905K 509.50% | 2.81M 210.83% | 1.41M 50.05% | 111K 92.10% | 2.94M 2,546.85% | 2.40M 18.18% | 7.94M 230.28% | -1.99M 125.05% | 1.82M 191.75% | |
accounts receivables | -40K - | 1.11M - | ||||||||||
inventory | 17K - | 42K 147.06% | 42K 0% | |||||||||
accounts payables | 480K - | -276K 157.50% | -276K 0% | 880K 418.84% | 136K - | 3.15M 2,219.12% | -838K 126.57% | 7.08M 944.51% | -2.03M 128.68% | 1.96M 196.65% | ||
other working capital | 20K - | 13K 35% | 25K 92.31% | 1.93M 7,632.00% | 1.41M 27.32% | -25K 101.78% | -216K 764% | 3.24M 1,600.93% | 863K 73.38% | 41K 95.25% | -137K 434.15% | |
other non cash items | 140K - | 2.59M 1,748.57% | 13.51M 421.91% | 1.70M 87.44% | 1.37M 19.15% | 10.18M 641.98% | 1.65M 83.84% | 18.36M 1,016.17% | 538K 97.07% | 10K 98.14% | -3.24M 32,530% | |
net cash provided by operating activities | -442K - | -1.75M 295.70% | -4.66M 166.27% | -1.93M 58.56% | -5.43M 181.35% | -10.68M 96.63% | -3.66M 65.73% | -7.26M 98.47% | -15.61M 114.90% | -15.22M 2.49% | -8.85M 41.83% | |
investments in property plant and equipment | -6K - | -1K 83.33% | -4K - | -36K 800% | ||||||||
acquisitions net | 200K - | |||||||||||
purchases of investments | -23.04M - | 12.14M 152.71% | -2.01M 116.54% | |||||||||
sales maturities of investments | 12.14M - | |||||||||||
other investing activites | -1K - | -12.14M - | ||||||||||
net cash used for investing activites | -6K - | -1K 83.33% | -1K 0% | -4K 300% | -36K 800% | 200K 655.56% | -23.04M - | 12.14M 152.71% | -2.01M 116.54% | |||
debt repayment | -8K - | -6K 25% | -4.42M - | -100K 97.73% | -12.53M 12,431% | -1.21M 90.38% | ||||||
common stock issued | 325K - | 1.36M 318.46% | 1.74M 28.01% | 24.68M 1,317.52% | 35K 99.86% | 6.27M 17,808.57% | ||||||
common stock repurchased | -224K - | |||||||||||
dividends paid | ||||||||||||
other financing activites | 433K - | 2.59M 497.92% | 3.85M 48.71% | 1.90M 50.60% | 5.99M 214.98% | 14.29M 138.47% | 2.17M 84.83% | 23.32M 976.19% | 18.84M 19.20% | -35K 100.19% | ||
net cash used provided by financing activities | 425K - | 2.58M 507.76% | 3.85M 49.05% | 1.90M 50.60% | 5.99M 214.98% | 10.20M 70.21% | 3.43M 66.39% | 12.53M 265.66% | 42.32M 237.70% | -224K 100.53% | 6.27M 2,898.21% | |
effect of forex changes on cash | -16K - | 1K - | ||||||||||
net change in cash | -80K - | 812K 1,115% | -808K 199.51% | -28K 96.53% | 557K 2,089.29% | -516K 192.64% | -32K 93.80% | 5.27M 16,565.63% | 3.67M 30.33% | -3.30M 189.78% | -4.59M 39.35% | |
cash at beginning of period | 123K - | 43K 65.04% | 855K 1,888.37% | 47K 94.50% | 19K 59.57% | 576K 2,931.58% | 60K 89.58% | 28K 53.33% | 5.30M 18,817.86% | 8.97M 69.30% | 5.67M 36.75% | |
cash at end of period | 43K - | 855K 1,888.37% | 47K 94.50% | 19K 59.57% | 576K 2,931.58% | 60K 89.58% | 28K 53.33% | 5.30M 18,817.86% | 8.97M 69.30% | 5.67M 36.75% | 1.08M 80.98% | |
operating cash flow | -442K - | -1.75M 295.70% | -4.66M 166.27% | -1.93M 58.56% | -5.43M 181.35% | -10.68M 96.63% | -3.66M 65.73% | -7.26M 98.47% | -15.61M 114.90% | -15.22M 2.49% | -8.85M 41.83% | |
capital expenditure | -6K - | -1K 83.33% | -4K - | -36K 800% | ||||||||
free cash flow | -442K - | -1.75M 297.06% | -4.66M 165.41% | -1.93M 58.57% | -5.43M 181.55% | -10.71M 97.15% | -3.66M 65.85% | -7.26M 98.47% | -15.61M 114.90% | -15.22M 2.49% | -8.85M 41.83% |
All numbers in USD (except ratios and percentages)